Lilly to boost obesity drug supply with US$3 billion expansion
ELI Lilly is spending another US$3 billion to build out its US manufacturing footprint as it ramps up production of ...
ELI Lilly is spending another US$3 billion to build out its US manufacturing footprint as it ramps up production of ...
ELI Lilly expects to start selling its highly popular weight-loss drug in Hong Kong as early as the end of ...
ELI Lilly is pouring US$4.5 billion into a new manufacturing plant in Indiana to make drugs for future clinical trials, ...
© 2024 forbes50under50 - All Rights Reserved.
© 2024 forbes50under50 - All Rights Reserved.